Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 8/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | AMY2A | P04746 | 1/20 | 0.43 |
| ▸ | FGF1 | P05230 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.42 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.40 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25733984 | 1.00 | LGALS8 (0.57) | LGALS8MEN1KMT2AAMY2AFGF1 | |
| SCHEMBL7150008 | 0.93 | LGALS8 (0.64) | LGALS8LGALS3 | |
| SCHEMBL7151226 | 0.93 | LGALS8 (0.64) | LGALS8LGALS3 | |
| SCHEMBL20371001 | 0.93 | LGALS8 (0.64) | LGALS8LGALS3 | |
| SCHEMBL14601942 | 0.93 | LGALS8 (0.64) | LGALS8LGALS3 | |
| SCHEMBL15119995 | 0.93 | LGALS8 (0.64) | LGALS8LGALS3 | |
| SCHEMBL7147929 | 0.93 | LGALS8 (0.64) | LGALS8LGALS3 | |
| SCHEMBL7153013 | 0.93 | LGALS8 (0.64) | LGALS8LGALS3 | |
| SCHEMBL15958810 | 0.92 | LGALS8 (0.54) | LGALS8MEN1KMT2AAMY2AFGF1 | |
| SCHEMBL10014246 | 0.92 | LGALS8 (0.54) | LGALS8MEN1KMT2AAMY2AFGF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230157285-A1 | LAMINARIN BASED FORMULATION FOR AGRICULTURAL APPLICATIONS | UPL Corporation Limited (MU) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157285-A1 | LAMINARIN BASED FORMULATION FOR AGRICULTURAL APPLICATIONS | AGL, LCT, ALDOA | LGALS8 372/4885MEN1 1806/4885KMT2A 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.